Who owns Maze Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MAZE from SEC Form 13F filings across 158 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 158 institutions disclosed 60.4M shares of Maze Therapeutics, Inc. worth $1.64B — about 99.2% of shares outstanding; the largest disclosed holder is Frazier Life Sciences Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
158
13F holders
$1.64B
value, 2026 filers
99.2%
of shares outstanding (60.4M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MAZE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 5.3M | $143.6M | 3.6% | 8.7% | +5.0% |
| 2 | ARCH Venture Management, LLC | 4.1M | $112.0M | 6.9% | 6.8% | 0.0% |
| 3 | Deep Track Capital, LP | 4.1M | $111.0M | 1.8% | 6.7% | +9.4% |
| 4 | TRV GP IV, LLC | 3.7M | $101.2M | 67.6% | 6.1% | -16.8% |
| 5 | BlackRock, Inc. | 3.7M | $100.9M | 0.0% | 6.1% | +6.0% |
| 6 | Janus Henderson Group Ltd.NEW | 3.4M | $92.7M | 0.0% | 5.6% | new |
| 7 | T. Rowe Price Investment Management, Inc. | 2.4M | $66.0M | 0.0% | 4% | -6.7% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 1.9M | $51.1M | 0.0% | 3.1% | +5.7% |
| 9 | a16z Capital Management, L.L.C. | 1.7M | $46.3M | 0.2% | 2.8% | 0.0% |
| 10 | CITADEL ADVISORS LLC | 1.6M | $42.9M | 0.0% | 2.6% | +85.3% |
| 11 | Venrock Adviser, LLC | 1.5M | $42.0M | 2.0% | 2.5% | -3.5% |
| 12 | Alphabet Inc. | 1.4M | $37.7M | 0.0% | 2.3% | 0.0% |
| 13 | JPMORGAN CHASE & CO | 1.2M | $32.9M | 0.0% | 2% | +26.0% |
| 14 | MARSHALL WACE, LLP | 1.2M | $31.7M | 0.0% | 1.9% | +27.5% |
| 15 | BRAIDWELL LP | 1.1M | $31.2M | 1.3% | 1.9% | +0.9% |
| 16 | FMR LLC | 1.1M | $30.8M | 0.0% | 1.9% | +7.2% |
| 17 | STATE STREET CORP | 1.1M | $30.5M | 0.0% | 1.8% | +12.5% |
| 18 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.1M | $30.1M | 0.1% | 1.8% | 0.0% |
| 19 | General Catalyst Group Management, LLC | 1.0M | $28.2M | 5.9% | 1.7% | 0.0% |
| 20 | GEODE CAPITAL MANAGEMENT, LLC | 955,071 | $26.0M | 0.0% | 1.6% | +11.3% |
| 21 | TRV GP V, LLC | 950,800 | $25.8M | 5.4% | 1.6% | 0.0% |
| 22 | Driehaus Capital Management LLC | 947,544 | $25.8M | 0.2% | 1.6% | -0.8% |
| 23 | Logos Global Management LP | 935,000 | $25.4M | 1.4% | 1.5% | -51.7% |
| 24 | GOLDMAN SACHS GROUP INC | 846,632 | $23.0M | 0.0% | 1.4% | +188.8% |
| 25 | Casdin Capital, LLC | 843,857 | $22.9M | 1.0% | 1.4% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.